Stocks and Investing Stocks and Investing
Tue, December 17, 2019
Mon, December 16, 2019
Fri, December 13, 2019
Thu, December 12, 2019
Wed, December 11, 2019
Tue, December 10, 2019
Mon, December 9, 2019

Yanan Zhu Maintained (BLUE) at Buy with Decreased Target to $160 on, Dec 9th, 2019


Published on 2024-10-26 18:54:29 - WOPRAI
  Print publication without navigation


Yanan Zhu of Wells Fargo, Maintained "bluebird bio, Inc." (BLUE) at Buy with Decreased Target from $242 to $160 on, Dec 9th, 2019.

Yanan has made no other calls on BLUE in the last 4 months.



There are 4 other peers that have a rating on BLUE. Out of the 4 peers that are also analyzing BLUE, 3 agree with Yanan's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Joshua Schimmer of "Evercore ISI Group" Downgraded from Buy to Hold and Held Target at $86 on, Tuesday, November 19th, 2019
  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $100 on, Friday, November 1st, 2019
  • Benjamin Burnett of "Stifel" Initiated at Hold and Held Target at $109 on, Tuesday, October 1st, 2019


This is the rating of the analyst that currently disagrees with Yanan


  • Mani Foroohar of "SVB Leerink" Upgraded from Hold to Buy and Held Target at $119 on, Tuesday, November 26th, 2019